Beam Therapeutics (BEAM) Other Gross PP&E Adjustments (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $93.5 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 24.2% to $93.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.5 million through Dec 2025, up 24.2% year-over-year, with the annual reading at $93.5 million for FY2025, 24.2% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $93.5 million at Beam Therapeutics, down from $96.2 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $111.5 million in Q2 2022, with the low at -$47.8 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $43.9 million, with a median of $56.0 million recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 508.2% in 2021, then surged 635.49% in 2023.
  • Over 5 years, Other Gross PP&E Adjustments stood at -$5.7 million in 2021, then skyrocketed by 459.54% to $20.5 million in 2022, then skyrocketed by 186.6% to $58.8 million in 2023, then grew by 27.95% to $75.3 million in 2024, then increased by 24.2% to $93.5 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $93.5 million, $96.2 million, and $88.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.